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Abstract
Thiol-disulfide interchange (“disulfide scrambling”) is a common mechanism of covalent
aggregation for protein drugs. Using tocinoic acid (cyclo-S-Cys-Tyr-Ile-Gln-Asn-Cys-(S);
TA(ox)) and glutathione (γGlu-Cys-Gly; GSH), our previous work demonstrated that thiol/
disulfide interchange is affected by lyophilization in a manner consistent with irreversible and
regioselective loss of TA(ox) (Zhang et al., 2009, J Pharm Sci 98/9: 3312–3318). Here, we explore
the contributions of stages of the lyophilization cycle to perturbations in thiol/disulfide
interchange in the TA/GSH system. TA(ox) and GSH were co-lyophilized from phosphate buffer
in the presence or absence of various excipients, then analyzed for TA(ox) and mixed disulfide
products by reverse phase high performance liquid chromatography (rp-HPLC). Perturbations
were found to occur primarily during freezing, before significant amounts of ice were removed by
sublimation. Addition of a lyoprotectant (sucrose), a cryoprotectant (Tween-20) and flash-freezing
influenced the product distribution only while ice was still present. Decreasing the redox potential
by the addition of oxidized glutathione (GSSG) affected the product distribution differently in
lyophilized samples and solution controls, but in neither case led to increased conservation of
TA(ox).
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INTRODUCTION
Therapeutic proteins are often formulated as lyophilized powders to improve stability and
preserve efficacy. Nevertheless, proteins can undergo a variety of physical and chemical
degradation processes in the solid state that can reduce potency and increase the potential for
immunogenic side effects. Aggregation is one of the most frequent types of protein
degradation in both solution and solid phases, and can be defined as the formation of
covalent and/or noncovalent intermolecular associations among protein molecules.
Aggregates have been implicated in life-threatening immunogenic reactions to protein drugs
and so must be eliminated during manufacturing, shipping and shelf-storage. One of the
most common routes to covalent protein aggregation is thiol-disulfide interchange. The
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reaction mechanism in solution has been well established and involves the pH-dependent
generation of the thiolate anion as the rate-determining step, followed by its reaction with
the disulfide in an SN2 nucleophilic displacement.1,2 Whether this mechanism applies to
solid forms remains unclear, however, though reducible aggregates have been identified in
samples of lyophilized proteins and attributed to thiol-disulfide interchange.3
Previous studies in our laboratories explored thiol-disulfide interchange during
lyophilization, using tocinoic acid (cyclo-S-Cys-Tyr-Ile-Gln-Asn-Cys-(S), TA(ox)) and
glutathione (γGlu-Cys-Gly, GSH, reduced) as model peptides.4 The TA/GSH system is a
model for thiol-disulfide interchange in larger proteins, in which native disulfide bonds (i.e.,
cystine) may react with free thiol groups that are an endogenous part of the protein structure
(e.g., Cys side chain) or are formed by partial reduction of disulfides by other means (e.g., β-
elimination). Our studies drew on earlier work by Rabenstein and Yeo,2 who demonstrated
that, in solution, TA(ox) rapidly reacts with GSH via thiol-disulfide interchange to produce
two singly substituted mixed disulfides, SMD1 ((HS)-Cys-Tyr-Ile-Gln-Asn-Cys-(S)-SG)
and SMD2 (GS-(S)-Cys-Tyr-Ile-Gln-Asn-Cys-(SH)) with the disulfide bond at either
terminus (Fig. 1).5 The single mixed disulfides react with GSH to produce the reduced form
of TA (TA(red)) and oxidized GSH (GSSG), or with GSSG to form the doubly substituted
(or “double mixed”) disulfide, DMD (GS-(S)-Cys-Tyr-Ile-Gln-Asn-Cys-(S)-SG) (Fig. 1).
The solution reactions were shown to be rapid and reversible, so that equilibrium is
established in minutes in neutral solution.2,5
Extending these studies to lyophilized solids, we demonstrated that the TA-derived peptides
(i.e., TA(ox), TA(red), SMD1, SMD2, and/or DMD; Fig. 1) were present following
lyophilization of TA(ox)/GSH solutions from neutral buffer, in keeping with the solution
mechanism.4 However, lyophilization caused a considerable shift in the relative amounts of
the five species. During lyophilization, TA(ox) was fully reduced to TA(red). TA(ox) was
not detected in samples immediately following lyophilization or after ten days of storage in
the solid form, suggesting that the reaction in solids is effectively irreversible. In addition,
only one of the single mixed disulfide products (SMD1) was detected in solids, indicating
that the reaction occurs preferentially on the less sterically hindered side of the disulfide
bond and so is regioselective.4 These differences in the distribution of TA-derived peptides
in the solution and lyophilized solids may be due to temperature-induced changes in the
kinetics and/or equilibria of thiol-disulfide interchange reactions during lyophilization, to
reduced mobility in the solid samples, or to interactions with the ice surface during freezing.
To the extent that the results are applicable to larger proteins, they suggest that native
disulfide bonds may be reduced during lyophilization in the presence of free thiol groups.
Reduced disulfides may participate in additional reactions during subsequent shelf storage,
contributing to instability in the lyophilized product.
While our previous results provide an indication that lyophilization alters the thiol-disulfide
product distribution, they are limited in that samples were analyzed only before and after
lyophilization. In the work reported here, we identify stages of the lyophilization cycle
responsible for process-induced changes and explore the ability of formulation additives
(i.e., excipients) and flash freezing to stabilize the native disulfide during lyophilization. The
studies are intended to provide mechanistic insight into the factors affecting thiol-disulfide
interchange during lyophilization and to evaluate practical strategies for stabilization of
native disulfide bonds.
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TA(ox), GSH, GSSG, acetonitrile (CHROMASOLV® gradient grade), and sucrose were
obtained from Sigma–Aldrich Chemical Co. (St. Louis, MO). Sodium dihydrogen phosphate
(NaH2PO4), potassium hydrogen phosphate (K2HPO4), potassium dihydrogen phosphate
(KH2HPO4), and potassium chloride (KCl), all ACS grade, and hydrochloric acid (HCl),
phosphoric acid (H3PO4, 85%), and Tween-20 (polysorbate 20, enzyme grade) were
purchased from Fisher Scientific Co. (Fair Lawn, NJ).
Preparation of Stock Solutions
Stock solutions of TA(ox) (100 μM) and GSH (8 mM) were prepared in phosphate buffer
(60 mM K2HPO4/KH2PO4, pH 7.0, 150 mM KCl). The TA(ox)/GSH reaction mixture for
lyophilization, containing 60 mM K2HPO4/KH2PO4, pH 7.0, 4 mM GSH, 50 μM TA(ox)
and 150 mM KCl, was prepared by mixing 100 μL of 8 mM GSH with 100 μL of 100 μM
TA(ox) on ice followed by immediate cooling at −80°C for 30 min. Samples were also
prepared with the addition of 3% (w/v) sucrose, a common lyoprotectant, or 0.1% (v/v)
Tween-20, a pharmaceutically acceptable surfactant and cryoprotectant, to evaluate their
ability to preserve the native disulfide. To explore the effects of redox buffer on product
distribution, solutions containing both GSSG and GSH were prepared in phosphate buffer
(4, 8, or 16 mM GSSG and 8 mM GSH in 60 mM K2HPO4/KH2PO4, pH 7.0, 150 mM KCl)
and mixed with the TA(ox) stock solution. Some excipient-free samples were also subjected
to flash freezing in liquid nitrogen at −80°C prior to lyophilization, a process that minimizes
the formation of crystalline ice during freezing.
Lyophilization and Sample Analysis
Solid samples were prepared by lyophilization from TA(ox)/GSH reaction mixture using a
programmable bench top lyophilizer (VirTis, Gardner, NY) and a fixed lyophilization cycle
(Tab. 1). Samples were prefrozen in a −80°C freezer before the lyophilization cycle was
initiated (Step 1, Tab. 1). As a control, excipient-free samples (i.e., containing 60 mM K2
HPO4/KH2PO4, pH 7.0, 4 mM GSH, 50 μM TA(ox), and 150 mM KCl) were wrapped in
film, placed in the lyophilizer and exposed to the same temperature cycle as the lyophilized
samples. These controls are termed “nonlyophilized,” since removal of water by sublimation
is prevented by covering the lyophilization vials. In effect, these samples are frozen (and
later thawed), but not dried. As additional controls, samples held at room temperature for 5
min and at −80°C for 30 min were also analyzed.
At the end of each lyophilization step, the cycle was stopped and triplicate samples were
withdrawn. Fully lyophilized powder samples were reconstituted in 200 μL 0.1 M HCl to
quench the reaction. In frozen and liquid samples, the reaction was quenched by adding 4 μL
5 M HCl. The distribution of TA-derived peptides at each lyophilization step was
determined by rp-HPLC with u.v. detection at 215 nm, as described previously,4 using an
injection volume of 30 μL. The relative amounts of the five peptides (TA(ox), TA(red),
SMD1, SMD2, DMD; Fig. 1) were calculated as a weighted percentage of the total
chromatographic peak area at 215 nm. Since synthetic standards were not available for each
of the five TA-derived peptides, peak areas were weighted to correct for differences in
peptide extinction coefficients at 214 nm (ε214), estimated using the method of Moffatt et al.
6 Estimated ε214 values were 25,677 for TA(ox) and TA(red), 31369 for SMD1 and SMD2,
and 37061 for DMD. Thus recorded peak areas for SMD1 and SMD2 were multiplied by
0.819 (=25677/31369), and those for DMD by 0.693 (25677/37061). All measurements were
performed in triplicate and errors are reported as standard deviations of the mean. Though
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this approach is justified for the chemically similar TA-derived peptides, the reported values
of “% total peptide” should be regarded as semi-quantitative.
Mass Loss and Water Content
Mass loss was determined by weighing the sample at the beginning and end of each
lyophilization step. Water content was analyzed by thermogravimetric analysis (TGA) (Q50,
TA Instruments, New Castle, DE). Temperature in the TGA was increased from ambient to
105°C at 10°C/min, followed by an isothermal step at 105°C for 15 min, and then ramping
to 150°C at 10°C/min. Mass loss and water content values were determined in triplicate.
These measurements confirmed that water removal is complete by the end of 12.5 h, the end
of Step 4 of this lyophilization cycle (Tab. 1). No additional mass changes were observed
during subsequent steps in lyophilization (not shown).
RESULTS AND DISCUSSION
Effect of Lyophilization on Product Distribution
Changes in the distribution of the five TA-derived peptides (TA(ox), TA(red), SMD1,
SMD2, and DMD) during lyophilization are shown in Figure 2. Initially, neutral solution
samples contained mostly TA(ox), with smaller amounts of SMD1, SMD2, and DMD (Fig.
2A). TA(red) content was not significantly different from baseline (Fig. 2A). It is reasonable
to expect that these initial solution samples of TA/GSH are at equilibrium based on prior
literature reports.2,5 However, the time required to reach equilibrium in frozen or dried
samples is not known, so the product distributions of samples taken during lyophilization
should not be regarded as equilibrium distributions.
Notable changes in the distribution of TA-derived peptides occurred during freezing (Fig.
2B,C; Steps 1 and 2, Tab. 1). Initial freezing at −80°C for 30 min (Fig. 2B; Step 1, Tab. 1)
produced a significant loss in TA(ox) with a corresponding increase in SMD1. TA(red) was
present at levels somewhat greater than in the initial solution (Fig. 2A vs. B). Continued
freezing at −35°C for 2 h (Step 2, Tab. 1) resulted in additional loss of TA(ox) and further
increases in TA(red) (Fig. 2C). Levels of DMD, SMD1, and SMD2 were comparable to
those at the end of the preceding step (Fig. 2C vs. B). Throughout freezing, SMD2 and
DMD remained at levels similar to those in the initial solution (Fig. 2A vs. B,C).
During primary drying, samples subjected to lyophilization (i.e., in open vials) maintained
the TA product distribution produced during freezing, while nonlyophilized samples (i.e., in
covered vials) showed increasing reversion to the initial solution distribution (Fig. 2A vs.
D,E). Initial primary drying at −35°C for 2 h under 100 mTorr vacuum produced some
increases in TA(red) with corresponding loss of SMD1 relative to the previous step.
Differences between the lyophilized samples and “nonlyophilized” controls were first
observed at this step (Fig. 2D vs. C). Continued primary drying at −5°C for 8 h under 100
mTorr vacuum (Fig. 2E; Step 4, Tab. 1) produced marked differences in the lyophilized and
nonlyophilized samples. In lyophilized samples, TA(red) and SMD1 were major products
and were present at levels comparable to the previous step (Fig. 2E vs. D), while
nonlyophilized samples show some recovery of the parent disulfide, TA(ox) (Fig. 2E).
Continued drying produced few additional changes in either the lyophilized or
nonlyophilized samples (Fig. 2F–H; Steps 5–7, Tab. 1). TA(red) and SMD1 remained the
major products in lyophilized samples, while the profile in nonlyophilized controls was
dominated by TA(ox). At this stage, the nonlyophilized samples were again in solution
form, while lyophilized samples were dried powders. Variability in the nonlyophilized
samples at the end of the lyophilization cycle may be due to imperfect sealing of the vials
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(Fig. 2G), so that some water was lost by evaporation as the samples returned to ambient
temperature.
Taken together, the results indicate that changes in the distribution of TA-derived peptides
during lyophilization occur primarily during freezing, before water is removed by
sublimation (Fig. 2A–C). The results are consistent with: (i) apparent irreversibility of thiol-
disulfide interchange in solid samples of TA(ox) and GSH to produce single mixed
disulfides and (ii) regioselectivity in the reaction to preferentially form the single mixed
disulfide on less hindered side of the bond (SMD1, Fig. 1), as we reported previously.4
However, these changes may actually reflect physical changes in the sample rather than
changes in mechanism. Accordingly, samples were perturbed by flash freezing and by the
inclusion of excipients to modify the physical properties of the samples.
Effects of Flash Freezing, Tween-20, and Sucrose
Since changes in the distribution of TA-derived peptides occurred primarily during freezing,
it is reasonable to suspect that interactions of the peptides with the ice surface may be
involved. For example, adsorption of TA(ox) to the ice surface through hydrophobic or
hydrogen-bonding interactions may allow thiol-disulfide interchange to occur as a
heterogeneous reaction. Site-specific interactions of TA(ox) with the ice surface (e.g.,
through hydrogen bonding with the Tyr residue) may promote ring opening on the less
hindered side of the TA(ox) disulfide, and thus may partially explain the apparent
regioselectivity observed here. Similar site-specific hydrogen-bonding interactions have
been implicated in the irreversible adsorption of antifreeze proteins to ice in the tissues of
polar fish, an interaction that protects the fish from freezing by limiting ice crystal growth.7
Interestingly, a sub-class of these naturally occurring antifreeze proteins (Type II) is
comprised of disulfide-rich globular proteins.8 Here, flash freezing and the inclusion of the
excipients Tween-20 and sucrose were employed in an attempt to influence any ice-peptide
interactions.
Flash freezing limits the time available for ice crystal growth, producing amorphous ice or
crystalline forms with smaller crystal size. To accelerate freezing, samples were flash frozen
in liquid nitrogen for 30 min prior to initiating the lyophilization cycle. At the end of Step 1,
flash frozen samples showed greater retention of TA(ox) and less SMD1 than controls that
were not flash frozen (Fig. 3). However, no significant differences in flash frozen and
control samples were observed during the rest of the lyophilization cycle (data not shown).
Flash frozen samples stored at −80°C for up to 4 days show a product distribution similar to
that observed after 30 min (data not shown).
The ability of the cyroprotectant Tween-20 to preserve TA(ox) during freezing was also
evaluated. During lyophilization, surfactants such as Tween-20 may compete with the
amphiphilic TA-peptides for binding to the ice surface, limiting peptide surface adsorption.
9,10 As with flash freezing, inclusion of Tween-20 resulted in greater retention of TA(ox)
and lower levels of SMD1 at the end of Step 1 (Fig. 3), but had no effect on the production
distribution during subsequent steps (data not shown).
Carbohydrates such as sucrose and trehalose have been used to retard protein aggregation in
amorphous solids, and are thought to act by increasing Tg and limiting mobility in the solid,
or by replacing the protein’s hydrogen bonds to water to stabilize the native structure.11–13
To examine the effect of a carbohydrate excipient on thiol-disulfide interchange, 3% (w/w)
sucrose was co-lyophilized with the TA(ox)-GSH mixture. Sucrose had no effect on the
distribution of TA-derived peptides after 5 min at room temperature (data not shown), but
improved retention of TA(ox) during freezing and the initial stage of primary drying (Fig.
4A–C). These differences were not maintained through the later steps of the lyophilization
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cycle, however; at Step 4 (Fig. 4D) and subsequent stages, sucrose-containing and control
samples showed similar product distributions (data not shown).
The results on the effects of flash freezing and Tween-20 on thiol-disulfide interchange
during freezing provide additional support for a role of the ice surface (Fig. 3). As noted
above, flash freezing is expected to limit crystal growth while inclusion of the surfactant
Tween-20 may interfere with the binding of TA(ox) and/or TA-derived peptides to the ice
surface. That both treatments protected TA(ox) during initial freezing (Fig. 3) is consistent
with an effect of the ice surface; elimination of these effects during drying (when ice is
removed) is an additional indication that they act on the ice-surface. Sucrose may cause
similar effects in this system (Fig. 4) by hydrogen bonding to the ice surface and interfering
with TA(ox)-ice interactions.
Effect of Redox Buffering
While the data support a role for the ice surface in influencing product distribution, an
alternative explanation is that the formation of TA(red) from TA(ox) during freezing is
simply the result of a chemically reductive environment (Fig. 2). If this were the case, the
addition of oxidized GSSG at constant GSH might be expected to produce changes in redox
potential that would protect TA(ox). In solution, increasing levels of GSSG corresponded to
increases in DMD and decreases in TA(red) (i.e., increasing R in Fig. 5A, where R =
[GSSG]/([GSSG] + [GSH]), a measure of the redox potential). Solution TA(ox) levels
decreased only at the highest GSSG content (R = 0.67), while SMD1 and SMD2 levels were
essentially unaffected by changes in GSSG (Fig. 5A). Similar trends in TA(red) and DMD
were observed in lyophilized samples (Fig. 5B). SMD1 showed greater dependence on
GSSG in lyophilized solids than in solution, initially increasing with GSSG content to R =
0.50 then decreasing at R = 0.67. The results are consistent with stoichiometric effects of
GSSG and GSH in their reactions with SMD1 and SMD2 to produce TA(red) and DMD in
both solution and solid samples (Fig. 1). The lack of an effect on TA(ox) levels is consistent
with the constant levels of GSH in these experiments, since GSSG is not involved in the
forward or reverse reactions of TA(ox) (k1, k−1; Fig. 1), and with the relatively slow reverse
reaction to form TA(ox) from SMD1 and SMD2 (k−1; Fig. 1). The slow reverse reaction has
been reported for TA(ox) and related peptides in solution;2 our previous studies of the
reaction during lyophilization showed this step to be essentially irreversible.4
Thus, the addition of oxidized GSSG at constant GSH did not protect TA(ox) and changes in
redox potential appear to have little effect in this system. Studies of additional redox buffers
in which the species are not also reactants would be interesting and may allow better
discrimination of the effects of redox environment and reactant levels.
Implications for Protein Formulation
To the extent that the results obtained with these model peptides are applicable to larger
proteins, they have implications for the formulation of lyophilized protein drugs. The results
suggest that, in the presence of free thiols, disulfide bonds in proteins may undergo thiol-
disulfide interchange during the freezing stage of lyophilization to produce reduced disulfide
and single-mixed disulfide products. These process-induced changes can be delayed (i.e., to
a later stage in the lyophilization cycle) but not eliminated by the addition of surfactants
(e.g., Tween-20), lyoprotectants (e.g., sucrose) or by flash freezing. Similarly, adding a low
molecular weight disulfide (e.g., GSSG) alters the product distribution but does not preserve
the parent disulfide. Although thiol-disulfide exchange in solution is quenched at low pH,
formulating solutions or solids at low enough pH to protonate the thiol (pH <3) is
impractical. Thus, limiting free thiol content prior to lyophilization remains as a viable
method to prevent the reaction.
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Thiol-disulfide interchange reactions of tocinoic acid (cyclo Cys-Tyr-Ile-Gln-Asn-Cys;
TA(ox)) and reduced glutathione (γGlu-Cys-Gly; GSH) in solution. Reaction products are
reduced tocinoic acid (TA(red)), two singly substituted mixed disulfides (SMD1, SMD2),
the doubly substituted mixed disulfide (DMD), with structures as shown, as well as oxidized
glutathione (GSSG).
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Product distribution of the TA(ox)/GSH reaction mixture after the each step of the
lyophilization cycle (Tab. 1). Lyophilized samples (“lyophilized,” hatched bars) are
compared with control samples, which were covered to prevent water removal
(“nonlyophilized,” stippled bars) but followed the same temperature program. Samples were
analyzed after: (A) 5 min in solution at room temperature; (B) 30 min at −80°C without
vacuum (Tab. 1, Step 1); (C) an additional 2 h at −35°C without vacuum (Tab. 1, Step 2);
(D) an additional 2 h at −35°C with 100 mTorr vacuum (Tab. 1, Step 3); (E) an additional 8
h at −5°C with 100 mTorr vacuum (Tab. 1, Step 4); (F) an additional 6 h at 5°C with 100
mTorr vacuum (Tab. 1, Step 5); (G) an additional 6 h at 15°C with 100 mTorr vacuum (Tab.
1, Step 6); and (H) an additional 10 h at 25°C with 100 mTorr vacuum (Tab. 1, Step 7).
Lyophilized samples, n ≥ 6; nonlyophilized samples, n ≥ 3; ±SD.
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Effect of flash freezing and Tween-20 on the product distribution of the TA(ox)/GSH
reaction mixture at the end of initial freezing at −80°C (Tab. 1, Step 1). Lyophilized
samples, n ≥ 6; lyophilized samples with Tween-20 and flash freezing, n = 3; ±SD.
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Effect of sucrose on the product distribution of the TA(ox)/GSH reaction mixture during the
first four steps of the lyophilization cycle (Tab. 1). Samples were analyzed after: (A) 30 min
at −80°C without vacuum (Tab. 1, Step 1); (B) an additional 2 h at −35°C without vacuum
(Tab. 1, Step 2); (C) an additional 2 h at −35°C with 100 mTorr vacuum (Tab. 1, Step 3);
and (D) an additional 8 h at −5°C with 100 mTorr vacuum (Tab. 1, Step 4). Lyophilized
samples, n ≥ 6; lyophilized samples with sucrose, n ≥ 3; ±SD.
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The effect of GSSG on the product distribution of the TA(ox)/GSH reaction mixture in
solution (A) and in fully lyophilized solids (B) (i.e., after Step 7, Tab. 1). The initial solution
concentration of GSH was held constant at 8 mM and GSSG was added in varying amounts
to produce fractional molar GSSG content (R) of 0, 0.33, 0.50, and 0.67, where R = [GSSG]/
([GSSG] + [GSH]). n ≥ 3; ±SD.
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